Logotype for Sartorius Aktiengesellschaft

Sartorius (SRT) investor relations material

Sartorius Investor Presentation summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Sartorius Aktiengesellschaft
Investor Presentation summary21 Oct, 2025

Strategic focus and market positioning

  • Focuses on bioprocess solutions and lab products, targeting biopharma and life science markets with ~€3.4bn sales revenue and a 28% EBITDA margin in 2024.

  • Maintains a high share of recurring revenues (~75%) and a resilient global setup with significant investments in capacity and R&D.

  • Pursues growth through M&A, innovation, and integration of advanced technologies, including AI and automation.

  • Addresses all biopharma drug modalities, with strong exposure to cell and gene therapies, which represent over 10% of BPS sales.

  • Committed to sustainability and reduction of CO2 emission intensity as part of midterm targets.

Financial performance and guidance

  • Achieved 9M 2025 sales revenue of €2,611m (+7.5% cc), with underlying EBITDA up 12.8% and margin rising to 29.7%.

  • Net profit increased 17% to €244m (underlying), with reported net profit up 66% to €125m; free cash flow at €200m.

  • Deleveraging continues as planned, with net debt/EBITDA at 3.71x and a strong investment grade rating (BBB-, stable).

  • FY 2025 guidance: group sales growth ~7%, EBITDA margin slightly above 29.5%; BPS sales growth ~9%, LPS ~flat.

  • Capex ratio expected at ~12.5%, with net debt/EBITDA to decrease to ~3.5x by year-end.

Divisional highlights

  • Bioprocess Solutions (BPS): €2.7bn sales, 29.3% EBITDA margin, ~80% recurring revenue, robust growth in high-margin consumables.

  • BPS outperformed with 9M 2025 sales up 7.8% and EBITDA margin at 31.5%, driven by recurring business and economies of scale.

  • Lab Products & Services (LPS): €691m sales, 22.9% EBITDA margin, 50% recurring revenue, portfolio includes lab instruments, consumables, and software.

  • LPS saw resilient performance despite a challenging environment, with recurring business growth and MATTEK acquisition contributing to results.

  • BioAnalytics portfolio increasingly synergetic with BPS, leveraging automation, AI, and data analytics to accelerate drug development.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Sartorius earnings date

Logotype for Sartorius Aktiengesellschaft
Q4 202527 Jan, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Sartorius earnings date

Logotype for Sartorius Aktiengesellschaft
Q4 202527 Jan, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Sartorius Aktiengesellschaft is a global leader in the bioprocess solutions, lab products, and services business. Established as a family business in 1870, Sartorius has long-term experience in development and production at its sites in Germany, Japan, China and the United States. Sartorius is organized into three segments: Bioprocess Solutions, Laboratory Products and Services. Its enterprise-wide approach combined with its commitment to customer satisfaction has enabled Sartorius to provide comprehensive products and services which support the development, qualification and manufacturing of biopharmaceuticals as well as research labs around the world.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage